Patents by Inventor Hee-sup Shin

Hee-sup Shin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090126031
    Abstract: The present invention relates to a novel use of an ?1G T-type calcium channel transgenic mouse as a nervous disease model, more particularly, a novel use of a mouse deficient in ?1G T-type calcium channel showing novelty-seeking and alcohol preference as a nervous disease model for human nervous related diseases such as novelty-seeking character, alcoholism, anxiety and emotion disorder by stress, etc. The ?1G T-type channel transgenic mice showing novelty-seeking and alcohol preference of the present invention can be effectively used for the development of a medicine and a therapeutic method for human nervous diseases.
    Type: Application
    Filed: January 9, 2009
    Publication date: May 14, 2009
    Inventors: Hee-Sup Shin, Daesoo Kim, Jungryun Lee, Soonwook Choi, Chanki Kim, Sukchan Lee
  • Patent number: 7466063
    Abstract: A micro manipulator for electrode movement, a driving method thereof, and a brain signal measuring device using the same are provided.
    Type: Grant
    Filed: June 27, 2006
    Date of Patent: December 16, 2008
    Assignee: Korea Institute of Science and Technology
    Inventors: Byung-kyu Kim, Suk-ho Park, Hee-sup Shin, Dae-soo Kim, Hyun-jun Park, Jong-oh Park
  • Publication number: 20080201787
    Abstract: The disclosure concerns a method for resistance of epilepsy by suppressing the function of alpha 1G protein of T-type calcium channels, use of suppressor of alpha 1G protein for prevention or treatment for epilepsy, knockout mice resisting epilepsy by disrupting alpha 1G subunit of T-type calcium channel, and preparation method thereof. The ?1G-knockout transgenic mouse can be used for investigating the relationship between diseases particularly neuropathy or psychopathy and the function of ?1G T-type calcium channel via various behavioral tests since ?1G subunit is mainly expression in central nervous system (CNS) and pheripheral nervous system (PNS). Further, the ?1G-knockout transgenic mouse can be used for screening antileptic agents.
    Type: Application
    Filed: November 23, 2007
    Publication date: August 21, 2008
    Inventors: Hee-Sup Shin, Daesoo Kim, Sehoon Keum, Inseon Song
  • Publication number: 20080015163
    Abstract: The present invention relates to a novel use of an ?1G T-type calcium channel transgenic mouse as a nervous disease model, more particularly, a novel use of a mouse deficient in ?1G T-type calcium channel showing novelty-seeking and alcohol preference as a nervous disease model for human nervous related diseases such as novelty-seeking character, alcoholism, anxiety and emotion disorder by stress, etc. The ?1G T-type channel transgenic mice showing novelty-seeking and alcohol preference of the present invention can be effectively used for the development of a medicine and a therapeutic method for human nervous diseases.
    Type: Application
    Filed: July 25, 2007
    Publication date: January 17, 2008
    Inventors: Hee-Sup Shin, Daesoo Kim, Jungryun Lee, Soonwook Choi, Chanki Kim, Sukchan Lee
  • Publication number: 20070296310
    Abstract: A micro manipulator for electrode movement, a driving method thereof, and a brain signal measuring device using the same are provided.
    Type: Application
    Filed: June 27, 2006
    Publication date: December 27, 2007
    Inventors: Byung-kyu Kim, Suk-ho Park, Hee-sup Shin, Dae-soo Kim, Hyun-jun Park, Jong-oh Park
  • Publication number: 20070228868
    Abstract: A polymer linear actuator for a micro electro mechanical system (MEMS) and a micro manipulator for a measurement device of cranial nerve signal using the same are provided. The polymer linear actuator has first and second bodies positioned spaced apart to a distance from each other, and one or more pairs of V-type moving units connecting the first and second bodies together, wherein the moving units in pair are opposed to each other to convert a rotation motion of the respective moving units into a linear motion, thereby causing the first and second bodies to move linearly.
    Type: Application
    Filed: August 30, 2006
    Publication date: October 4, 2007
    Inventors: Suk-ho Park, Jin-seok Kim, Ju-hee Hong, Sung-wook Yang, Hee-sup Shin, Dong-won Lee, Suk-chan Lee, Hui-su Kim
  • Publication number: 20060194253
    Abstract: The present invention relates to a cell line in which a potassium channel is introduced. More specifically, it is a cell line capable of activating the T-type ?1H calcium channel by depolarization wherein a vector encoding a potassium channel is introduced. Since the cell line of the present invention is available for a high throughput screening of candidate T-type ?1H calcium channel inhibitors, it may accelerate the development of therapeutic agents for diseases related to T-type ?1H calcium channels.
    Type: Application
    Filed: September 12, 2005
    Publication date: August 31, 2006
    Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Seong-Woo JEONG, Jung-Ha LEE, Byong-Gon PARK, Edward Perez-Reyes, Dong Jin KIM, Hee Sup SHIN
  • Publication number: 20060025397
    Abstract: The disclosure concerns a method for resistance of epilepsy by suppressing the function of alpha 1 G protein of T-type calcium channels, use of suppressor of alpha 1 G protein for prevention or treatment for epilepsy, knockout mice resisting epilepsy by disrupting alpha 1 G subunit of T-type calcium channel, and preparation method thereof. In addition, suppressing alpha 1 G protein of T-type calcium channels does not occur epilepsy, and alpha 1 G-deficient mice are useful to study of mechanism related to epilepsy.
    Type: Application
    Filed: January 18, 2002
    Publication date: February 2, 2006
    Inventors: Hee-Sup Shin, Daesoo Kim, Sehoon Keum, Inseon Song
  • Publication number: 20060009444
    Abstract: The present invention relates to the method for decreasing depression, more particularly to the method for decreasing depression by inhibiting the activity of N-type calcium channel. According to the present invention, inhibiting material of N-type calcium channel activity can effectively be used for the depression remedy. Also, anti-depression reagent can be screened using N-type calcium channel.
    Type: Application
    Filed: October 16, 2003
    Publication date: January 12, 2006
    Inventors: Hee-Sup Shin, Chanki Kim
  • Publication number: 20050251874
    Abstract: The present invention relates to a novel use of an ?1G T-type calcium channel transgenic mouse as a nervous disease model, more particularly, a novel use of a mouse deficient in ?1G T-type calcium channel showing novelty-seeking and alcohol preference as a nervous disease model for human nervous related diseases such as novelty-seeking character, alcoholism, anxiety and emotion disorder by stress, etc. The ?1G T-type channel transgenic mice showing novelty-seeking and alcohol preference of the present invention can be effectively used for the development of a medicine and a therapeutic method for human nervous diseases.
    Type: Application
    Filed: October 22, 2004
    Publication date: November 10, 2005
    Inventors: Hee-Sup Shin, Daesoo Kim, Jungryun Lee, Soonwook Choi, Chanki Kim, Sukchan Lee
  • Publication number: 20030086980
    Abstract: The disclosure concerns a method for the suppression of visceral pain by regulating the T-type calcium channel; a visceral pain inhibitor that includes a T-type calcium channel inhibitor as an effective ingredient; and a method of screening a visceral pain inhibitor by investigating the suppression activity of T-type calcium channels. Particularly, the present invention relates to a method for the suppression of visceral pain by regulating an alpha 1G T-type calcium channel in the central nervous system and alpha 1H and alpha 1I T-type calcium channels in the peripheral nervous system; a visceral pain inhibitor that includes a T-type calcium channel inhibitor as an effective ingredient; and a method of screening a visceral pain inhibitor by investigating the suppression activity of T-type calcium channels. The method of the present invention can be effectively used to suppress visceral pain by regulating T-type calcium channel in a precise mechanism without any side effects.
    Type: Application
    Filed: October 31, 2002
    Publication date: May 8, 2003
    Inventors: Hee-Sup Shin, Dae-Soo Kim, Chan-Ki Kim
  • Patent number: 5843773
    Abstract: A new Bcl-2 related gene "Bfl-1", a polypeptide encoded by said gene, and a plasmid and a transformant comprising said gene are disclosed. The gene can be used to detect cancer.
    Type: Grant
    Filed: November 22, 1996
    Date of Patent: December 1, 1998
    Assignees: Korea Green Cross Corporation, Postech Foundation
    Inventors: Hee Sup Shin, Young Chul Sung, Seok Il Hong, Sun Sim Choi, Jin Won Yun, Eun Kyoung Choi, In Chul Park